These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 30414369)

  • 1. Non-invasive Oxygen-Ozone therapy in treating digital ulcers of patients with systemic sclerosis.
    Hassanien M; Rashad S; Mohamed N; Elawamy A; Ghaly MS
    Acta Reumatol Port; 2018; 43(3):210-216. PubMed ID: 30414369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of local oxygen-ozone therapy for the treatment of digital ulcer refractory to medical therapy in systemic sclerosis: A randomized controlled study.
    Kaymaz S; Karasu U; Alkan H; Ulutaş F; Albayrak Yaşar C; Dündar Ök Z; Çobankara V; Yiğit M; Yıldız N; Ardıç F
    Mod Rheumatol; 2022 Oct; 32(6):1102-1107. PubMed ID: 34865095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statins: potentially useful in therapy of systemic sclerosis-related Raynaud's phenomenon and digital ulcers.
    Abou-Raya A; Abou-Raya S; Helmii M
    J Rheumatol; 2008 Sep; 35(9):1801-8. PubMed ID: 18709692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of adjunctive ambrisentan treatment for digital ulcers in patients with systemic sclerosis: a case series study
    Xu B; Yu Y; Liang J; Xu G; Chen W; Lin J; Hu S
    J Dermatolog Treat; 2023 Dec; 34(1):2276046. PubMed ID: 38073230
    [No Abstract]   [Full Text] [Related]  

  • 5. Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial.
    Matucci-Cerinic M; Denton CP; Furst DE; Mayes MD; Hsu VM; Carpentier P; Wigley FM; Black CM; Fessler BJ; Merkel PA; Pope JE; Sweiss NJ; Doyle MK; Hellmich B; Medsger TA; Morganti A; Kramer F; Korn JH; Seibold JR
    Ann Rheum Dis; 2011 Jan; 70(1):32-8. PubMed ID: 20805294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A 4-week comparison of capillaroscopy changes, healing effect, and cost-effectiveness of botulinum toxin-A vs prostaglandin analog infusion in refractory digital ulcers in systemic sclerosis.
    Shenavandeh S; Sepaskhah M; Dehghani S; Nazarinia M
    Clin Rheumatol; 2022 Jan; 41(1):95-104. PubMed ID: 34471968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Digital ulcers in scleroderma patients: A retrospective observational study.
    De Cata A; Inglese M; Molinaro F; De Cosmo S; Rubino R; Bernal M; Mazzoccoli G
    Int J Immunopathol Pharmacol; 2016 Jun; 29(2):180-7. PubMed ID: 26684622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased growth factors play a role in wound healing promoted by noninvasive oxygen-ozone therapy in diabetic patients with foot ulcers.
    Zhang J; Guan M; Xie C; Luo X; Zhang Q; Xue Y
    Oxid Med Cell Longev; 2014; 2014():273475. PubMed ID: 25089169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Digital ulcers: overt vascular disease in systemic sclerosis.
    Steen V; Denton CP; Pope JE; Matucci-Cerinic M
    Rheumatology (Oxford); 2009 Jun; 48 Suppl 3():iii19-24. PubMed ID: 19487218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-healing ischaemic digital ulcer in a systemic sclerosis patient: a challenging clinical case.
    Blaise S; Roustit M; Forli A; Imbert B; Cracowski JL
    Int Wound J; 2017 Dec; 14(6):978-981. PubMed ID: 28303689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parasympathetic activity increases with digital microvascular damage and vascular endothelial growth factor in systemic sclerosis.
    Gigante A; Margiotta D; Navarini L; Liberatori M; Barbano B; Tubani L; Afeltra A; Rosato E
    Clin Exp Rheumatol; 2018; 36 Suppl 113(4):24-27. PubMed ID: 29787366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Practical suggestions on intravenous iloprost in Raynaud's phenomenon and digital ulcer secondary to systemic sclerosis: Systematic literature review and expert consensus.
    Ingegnoli F; Schioppo T; Allanore Y; Caporali R; Colaci M; Distler O; Furst DE; Hunzelmann N; Iannone F; Khanna D; Matucci-Cerinic M
    Semin Arthritis Rheum; 2019 Feb; 48(4):686-693. PubMed ID: 29706243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A clinical comparison of an endothelin receptor antagonist and phosphodiesterase type 5 inhibitors for treating digital ulcers of systemic sclerosis.
    Chang SH; Jun JB; Lee YJ; Kang TY; Moon KW; Ju JH; Kang SW; Choi IA; Park YB; Lee SG; Lee SS; Heo NH; Lee EB
    Rheumatology (Oxford); 2021 Dec; 60(12):5814-5819. PubMed ID: 33576774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcium-channel blockers for Raynaud's phenomenon in systemic sclerosis.
    Thompson AE; Shea B; Welch V; Fenlon D; Pope JE
    Arthritis Rheum; 2001 Aug; 44(8):1841-7. PubMed ID: 11508437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of Botulinum Toxin B Injection for Raynaud's Phenomenon and Digital Ulcers in Patients with Systemic Sclerosis.
    Motegi SI; Uehara A; Yamada K; Sekiguchi A; Fujiwara C; Toki S; Date Y; Nakamura T; Ishikawa O
    Acta Derm Venereol; 2017 Jul; 97(7):843-850. PubMed ID: 28358168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Digital Ulcers in Systemic Sclerosis - How to Manage in 2013?
    Lambova S; Batalov A; Dobrev H; Sapundzhiev L; Müller-Ladner U
    Curr Rheumatol Rev; 2013; 9(4):274-8. PubMed ID: 26932293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin resistance is associated with digital ulcer in patients with systemic sclerosis.
    Park EK; Lee SG; Kim BH; Park JH; Lee S; Kim GT
    Clin Exp Rheumatol; 2016; 34 Suppl 100(5):85-91. PubMed ID: 27383539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developing a core set of outcome measure domains to study Raynaud's phenomenon and digital ulcers in systemic sclerosis: Report from OMERACT 2020.
    Maltez N; Hughes M; Brown E; Hickey V; Park H; Shea B; Herrick AL; Pauling JD; Proudman S; Merkel PA
    Semin Arthritis Rheum; 2021 Jun; 51(3):640-643. PubMed ID: 33947582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Botulinum toxin type A contribution in the treatment of Raynaud's phenomenon due to systemic sclerosis].
    Serri J; Legré R; Veit V; Guardia C; Gay AM
    Ann Chir Plast Esthet; 2013 Dec; 58(6):658-62. PubMed ID: 22204894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of sildenafil on digital ulcers in systemic sclerosis: analysis from a single centre pilot study.
    Brueckner CS; Becker MO; Kroencke T; Huscher D; Scherer HU; Worm M; Burmester G; Riemekasten G
    Ann Rheum Dis; 2010 Aug; 69(8):1475-8. PubMed ID: 19900936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.